BOLD
BOUNDLESS BIO (BOLD)
NASDAQ
$2.68+$0.08 (+3.08%)
Price as of Jun 23, 2026 7:59 PM EDT
  • $31.4M
    Market Cap
  • 140.74%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-44.8M
-18.86%
-55.3M
N/A
Depreciation and Amortization Expense
1.3M
+15.19%
1.1M
N/A
Total Operating Expenses
63.6M
-13.26%
73.3M
N/A
Operating Profit
-63.6M
-13.26%
-73.3M
N/A
Interest Income
5.4M
-32.12%
7.9M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
5.4M
-32.12%
7.9M
N/A
Total Nonoperating Income and Expense
5.4M
-32.25%
7.9M
N/A
Income before Taxes
-63.6M
-13.26%
-73.3M
N/A
Income Taxes
0
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-58.2M
-10.96%
-65.4M
N/A
Net Income from Continuing Operations Applicable to Common
-58.2M
-10.96%
-65.4M
N/A
Basic EPS and Net Income
-2.60
-32.47%
-3.85
N/A
Diluted EPS and Net Income
-2.60
-32.47%
-3.85
N/A
Basic Weighted Average Shares
22.4M
+31.65%
17.0M
N/A
Diluted Weighted Average Shares
22.4M
+31.65%
17.0M
N/A
Balance Sheet
Cash and Cash Equivalents
17.9M
-32.79%
26.6M
N/A
Short-Term Investments
89.7M
-28.53%
125.5M
N/A
Cash and Cash Equivalents and Short-Term Investments
107.6M
-29.28%
152.1M
N/A
Total Current Assets
109.6M
-29.00%
154.4M
N/A
Accumulated Depreciation
5.0M
+33.73%
3.7M
N/A
Property and Plant and Equipment and Net
3.2M
-25.57%
4.3M
N/A
Total Long-Term Assets
13,000
-86.87%
99,000
N/A
Total Assets
157.1M
-23.91%
206.4M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
12.5M
+54.11%
8.1M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
45.9M
-3.70%
47.6M
N/A
Total Liabilities
58.4M
+4.73%
55.8M
N/A
Retained Earnings
-259.7M
+28.89%
-201.5M
N/A
Total Stockholders Equity
98.7M
-34.51%
150.6M
N/A
Total Shares Outstanding
22.4M
+100,379.82%
22,300
N/A
Cash Flow
Cash from Operating Activities
-46.7M
-23.31%
-60.8M
N/A
Capital Expenditures
546,000
-78.47%
2.5M
N/A
Cash from Investing Activities
37.8M
+244.83%
-26.1M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
141,000
-99.84%
89.8M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-32.02%
N/A
N/A
N/A
Return on Equity
-46.69%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
8.74
N/A
N/A
N/A
Cash Ratio
1.43
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow